• 472 Citations
  • 12 h-Index
20082023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Christopher Vinnard is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Tuberculosis Medicine & Life Sciences
Meningeal Tuberculosis Medicine & Life Sciences
HIV Medicine & Life Sciences
Infection Medicine & Life Sciences
Latent Tuberculosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Isoniazid Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2023

Tuberculosis
Polymerase Chain Reaction
Infection
Drug Resistance
Pharmaceutical Preparations
Colorimetry
Tuberculosis
Pharmacokinetics
Urine
ROC Curve
Highly Active Antiretroviral Therapy
Rifampin
HIV
Tuberculosis
Botswana

Research Output 2008 2019

  • 472 Citations
  • 12 h-Index
  • 31 Article
  • 6 Review article
  • 4 Letter
  • 1 Editorial

Adipose tissue regulates pulmonary pathology during TB infection

Ayyappan, J. P., Ganapathi, U., Lizardo, K., Vinnard, C., Subbian, S., Perlin, D. & Nagajyothi, J. F., Mar 1 2019, In : mBio. 10, 2, e02771-18.

Research output: Contribution to journalArticle

Open Access
Mycobacterium tuberculosis
Adipose Tissue
Tuberculosis
Pathology
Lung

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis

Mezochow, A., Thakur, K. T., Zentner, I., Subbian, S., Kagan, L. & Vinnard, C., Jul 2019, In : International Journal of Infectious Diseases. 84, p. 15-21 7 p.

Research output: Contribution to journalArticle

Open Access
Meningeal Tuberculosis
Rifampin
Cerebrospinal Fluid
Microbial Sensitivity Tests
Therapeutics
8 Citations (Scopus)

Dual β-lactam combinations highly active against mycobacterium abscessus complex in vitro

Pandey, R., Chen, L., Manca, C., Jenkins, S., Glaser, L., Vinnard, C., Stone, G., Lee, J., Mathema, B., Nuermberger, E. L., Bonomo, R. A. & Kreiswirth, B. N., Jan 1 2019, In : mBio. 10, 1, e02895-18.

Research output: Contribution to journalArticle

Open Access
Lactams
Ceftazidime
Mycobacterium
Imipenem
Anti-Bacterial Agents

Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease

Marras, T. K., Mirsaeidi, M., Vinnard, C., Chan, E. D., Eagle, G., Zhang, R., Wang, P. & Zhang, Q., Nov 2 2019, In : Journal of Medical Economics. 22, 11, p. 1126-1133 8 p.

Research output: Contribution to journalArticle

Open Access
Lung Diseases
Economics
Guidelines
Health Expenditures
Therapeutics

Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study

Mehta, K., Ravimohan, S., Pasipanodya, J. G., Srivastava, S., Modongo, C., Zetola, N. M., Weissman, D., Ivaturi, V., Gumbo, T., Bisson, G. P. & Vinnard, C., Oct 1 2019, In : The Journal of antimicrobial chemotherapy. 74, 10, p. 2994-3002 9 p.

Research output: Contribution to journalArticle

Ethambutol
Tuberculosis
Pharmacokinetics
HIV
Population